Dr Paul Johnson
Joined the Board in October 2011.
Paul Johnson was born in Bromborough, Merseyside, and attended Wirral Grammar School prior to graduating with a BSc in Biochemistry from the University of Sheffield. In 1976 he gained a PhD in Biochemistry from the University of Liverpool. Paul researched coronary artery disease in the Regional Adult Cardio-Thoracic Unit in Liverpool before joining Eli Lilly and Company in 1980. Through his 27 years’ experience with Eli Lilly, both in Europe and the USA, Paul worked in the corporate and European headquarter operations at the executive level and in significant general management positions within HR, manufacturing, and R&D. During this time he also held global responsibilities covering India, China, Japan and Latin America. Prior to retiring in 2007 Paul held the position of Managing Director of Lilly Research UK based in Surrey. Paul was a Member of the Board of Directors of the UK affiliate and the Chairman of the Board of Trustees of the Lilly Pension Group.
Paul was an active Member of the Parliamentary & Scientific Committee, the CBI Science and Technology Committee, the National Association of Pension Funds Benefits Council and a Board Member of the Coalition for Medical Progress. He is currently a Member of the University of Liverpool Council.